Intimation of investors meeting.

Board & Shareholder Meetings View source PDF

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Aurobindo Pharma has informed the stock exchanges that company officials will participate in an in-person group investor meeting arranged by B&K Securities. The meeting is scheduled for June 25, 2025, from 5:00 PM to 6:00 PM IST in Hyderabad. The company has clarified that no unpublished price sensitive information (UPSI) will be discussed during the session. The schedule is subject to change depending on exigencies from either side.

Likely market impact

This is a routine investor engagement disclosure and is unlikely to have any material impact on the stock price, as no UPSI is being shared. It reflects normal outreach to institutional investors.